09.01.2025 19:04:02
|
Eterna Therapeutics Appoints Dr. Elena Ratner To Board Of Directors
(RTTNews) - Eterna Therapeutics (ERNA), a Massachusetts-based biopharmaceutical company, Thursday has announced the appointment of Elena Ratner, M.D., M.B.A., to its Board of Directors.
Dr. Ratner will guide Eterna's strategic initiatives in ovarian cancer, utilizing her expertise in obstetrics, gynecology, and reproductive sciences. Her leadership aims to advance innovative therapies in women's health, supported by Eterna's recent partnership with MD Anderson Cancer Center, which focuses on developing groundbreaking treatments for ovarian and breast cancers.
Dr. Ratner is a Professor in the Department of Obstetrics, Gynecology, and Reproductive Sciences at Yale University School of Medicine and Director of the Discovery to Cure Early Ovarian Cancer Detection program. She has received numerous accolades, including the 2024 David and Cindy Leffell Clinical Excellence Award and the 2015 Yale Cancer Center Award for Clinical Excellence.
Wednesday, ERNA closed at $0.3233 or 3.03% lower and after market hours rose and closed at $0.34 or 5.17%.
Analysen zu Eterna Therapeutics Inc Registered Shs
Im BX Morningcall werden folgende Aktien analysiert und erklärt:
NEU✅ Wolters Kluwer
NEU✅ American Express
NEU✅ Deckers Outdoor
inklusive Rebalancing:
❌ Synopsys
❌ Vertex Pharmaceuticals Inc
❌ Targa Resources
👉🏽 https://bxplus.ch/bx-musterportfolio/
Inside Trading & Investment
Mini-Futures auf SMI
Meistgelesene Nachrichten
Börse aktuell - Live Ticker
Nach US-Arbeitsmarktdaten: SMI und DAX gehen mit Abschlägen ins Wochenende -- US-Börsen verloren -- Asiens Börsen schliessen in RotDer heimische sowie der deutsche Aktienmarkt notierten zum Wochenende tiefer. Die US-Börsen präsentierten sich vor dem Wochenende tiefrot. In Asien zog es die Börsen am Freitag ins Minus.
finanzen.net News
Datum | Titel |
---|---|
{{ARTIKEL.NEWS.HEAD.DATUM | date : "HH:mm" }}
|
{{ARTIKEL.NEWS.BODY.TITEL}} |